Molecular Drivers of Tumor Progression and Malignancy

40 concepts39 papers1 proposal

In classical oncology, cancer development is often explained through a small handful of well-known, mutated oncogenes like RAS or MYC. However, tumor progression, metastasis, and immune evasion are frequently orchestrated by a much broader, hidden architecture of non-mutated molecules. Rather than acting as passive bystanders or mere biomarkers, a diverse array of circular RNAs (circRNAs), structural proteins, ion channels, and metabolic enzymes function as active drivers of malignancy when their expression levels are altered.

Understanding how these diverse components are hijacked reveals the underlying regulatory networks that sustain cancer hallmarks across different tissue types.

The Mechanics of Circular RNA Sponging Networks

One of the most prominent mechanisms driving tumor progression involves circular RNAs acting as competitive endogenous RNAs, or "molecular sponges."

To understand why this mechanism is so effective, consider the cell's default state of gene regulation. MicroRNAs (miRNAs) typically act as post-transcriptional brakes; they bind to specific messenger RNAs (mRNAs) to trigger their degradation or inhibit their translation, keeping oncogenic proteins in check. Circular RNAs, however, possess a covalently closed-loop structure that makes them highly resistant to exonuclease degradation. When a tumor cell overexpresses a specific circRNA, that molecule accumulates and presents multiple binding sites that sequester target miRNAs. By trapping these miRNAs, the circRNA effectively "sponges" them away from their natural mRNA targets, releasing the brakes and allowing downstream oncogenes to be translated at high volumes.

[Normal State]      miRNA ──┤ Target mRNA (Oncogene Silenced)

[Malignant State]   circRNA Overexpression ──> Sponges miRNA ──┤ (Target mRNA Free ──> Tumor Progression)

This regulatory cascade appears repeatedly across various malignancies:

The functional necessity of this mechanism is confirmed when the system is inverted. In Circular RNA Circ_0000098 Elevates ALX4 Expression via Adsorbing miR-1204 to Inhibit the Progression of Hepatocellular Carcinoma, Ming Li et al. observed that when a protective circRNA (circ_0000098) is abnormally downregulated in liver cancer, miR-1204 is left free to suppress the tumor suppressor ALX4, thereby accelerating epithelial-mesenchymal transition (EMT) and malignant progression.

Hijacking Structural and Ion Channel Machinery

Beyond non-coding RNAs, tumors frequently overexpress structural proteins and ion channels that are normally reserved for basic cellular maintenance, co-opting them to serve as upstream oncogenic switches.

For example, structural maintenance of chromosomes (SMC) proteins are traditionally understood as nuclear scaffold components required for DNA organization. However, Bo Zhou et al. discovered in A novel miR-219-SMC4-JAK2/Stat3 regulatory pathway in human hepatocellular carcinoma that when the microRNA miR-219 is lost in liver cancer, the resulting overexpression of SMC4 acts as a direct oncogenic driver. Instead of merely organizing DNA, excess SMC4 triggers the JAK2/Stat3 signaling pathway, actively promoting cellular invasion and proliferation. Similarly, Yang Liu demonstrated in CKAP2 Regulated by TFDP1 Promotes Metastasis and Proliferation of Colorectal Cancer through Affecting the Tumor Microenvironment that Cytoskeleton Associated Protein 2 (CKAP2) is hijacked in colorectal cancer to drive EMT and remodel the surrounding tumor microenvironment.

Ion channels are similarly co-opted to alter intracellular biophysics. In Transient receptor potential canonical 1 is a candidate treatment target for tongue squamous cell carcinoma by inhibiting growth and invasion through phosphatidylinositol 3-kinase and protein kinase B pathway, Lei Jiang demonstrated that the TRPC1 calcium channel is heavily overexpressed in tongue squamous cell carcinoma. This overabundance of TRPC1 facilitates an influx of calcium ions that continuously activates the PI3K/AKT pathway, providing a ligand-independent growth signal that fuels tumor invasion.

This concept of ligand-independent activation is a recurring theme; Fang He et al. showed in Copper (II) Ions Activate Ligand-Independent Receptor Tyrosine Kinase (RTK) Signaling Pathway that environmental factors, such as copper (II) ions within the microenvironment, can directly trigger receptor tyrosine kinase (RTK) signaling pathways in the absence of natural growth factors, accelerating cancer cell migration.

Metabolic Reprogramming and Immune Evasion

To sustain rapid growth and survive in hostile environments, overexpressed drivers also rewire tumor metabolism and alter the immune landscape.

In hepatocellular carcinoma, Haiyang Yu et al. found in D-xylose suppresses hepatocellular carcinoma progression by regulating dihydrodiol dehydrogenase and remodeling the immune microenvironment that the enzyme Dihydrodiol dehydrogenase (DHDH) is significantly upregulated, actively promoting tumor progression and helping cells evade immune surveillance. This metabolic rewiring can also be driven by non-coding RNA interactions. For instance, Juanyi Shi et al. demonstrated in m 6 A‐Modified circRAPGEF1 Interaction with IGF2BP3 Promotes Hepatocellular Carcinoma Progression via Reprogramming Aspartate Metabolism that an $m^6A$-modified circular RNA, circRAPGEF1, binds directly to the RNA-binding protein IGF2BP3. This interaction alters aspartate metabolism and stabilizes liver cancer stem cells, driving aggressive tumor growth.

Other non-coding RNAs target metabolic pathways to prevent programmed cell death. In Novel evidence for oncogenic piRNA‐823 as a promising prognostic biomarker and a potential therapeutic target in colorectal cancer, Muqing Yang et al. showed that piRNA-823 acts as an oncogenic driver by upregulating G6PD, which stabilizes HIF-1α and protects colorectal cancer cells from apoptosis. Similarly, enzymatic axes like the ZNF521/EBF1 pathway characterized by Yijiang Ni et al. in <scp>ZNF521</scp>/<scp>EBF1</scp> axis regulates <scp>AKR1B1</scp> to promote the proliferation, migration, and invasion of gastric cancer cells demonstrate that the upregulation of the metabolic enzyme AKR1B1 directly dictates the migratory and invasive capacity of gastric cancer cells.

Identifying Hub Genes for Targeted Therapy

By integrating large-scale transcriptomic data, Mendelian randomization, and functional validation, researchers can identify central "hub genes" that serve as critical vulnerabilities in these overexpressed networks. A pan-cancer analysis by Yanxing Li et al. in Multi-omics pan-cancer analyses identify MCM4 as a promising prognostic and diagnostic biomarker illustrated that the DNA replication protein MCM4 is universally upregulated across most major cancer types and is essential for cancer cell survival, making it a prime candidate for targeted therapies.

When these hub genes are identified, they open up precise therapeutic strategies:

Ultimately, these studies demonstrate that tumor progression relies on a highly coordinated upregulation of non-coding RNAs and functional proteins. Mapping these specific regulatory axes moves oncology beyond generic biomarkers, providing precise molecular targets to disrupt the core machinery driving cancer malignancy.

Key Foundational Work

Bioinformatic analysis of the membrane cofactor protein CD46 and microRNA expression in hepatocellular carcinoma (2013) — contributed 1 concept elements to this direction.
A novel miR-219-SMC4-JAK2/Stat3 regulatory pathway in human hepatocellular carcinoma (2014) — contributed 1 concept elements to this direction.
History & citationVersion 1 · 2026-10-04

Current · Permanent link

View frozen version 1

Cite this direction

Latest version (a living page):

@misc{lacuna_oncogene_overexpression_in_cancer_0d164343,
  title = {oncogene overexpression in cancer},
  author = {{Lacuna}},
  howpublished = {Lacuna research direction},
  year = {2026},
  url = {https://lacuna.tiptreesystems.com/direction/oncogene-overexpression-in-cancer/rdr_0d16434349cd43aeafca9c3b78511ad2},
  note = {Latest version of a living research direction; cite a version for a fixed text. Accessed 2026-11-21},
}

This exact version (version 1, frozen text):

@misc{lacuna_oncogene_overexpression_in_cancer_0d164343_v1,
  title = {oncogene overexpression in cancer},
  author = {{Lacuna}},
  howpublished = {Lacuna research direction},
  year = {2026},
  url = {https://lacuna.tiptreesystems.com/direction/oncogene-overexpression-in-cancer/rdr_0d16434349cd43aeafca9c3b78511ad2/v/1},
  note = {Version 1, frozen 2026-10-04. Accessed 2026-11-21},
}
About

These directions overlap with this one through shared papers.

See something wrong? Report a mistake